Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 9900
118th Congress(2023-2024)
BioTech Innovation and National Security Continuation Act
Introduced
Introduced
Introduced in House on Oct 1, 2024
Overview
Text
Introduced in House 
Oct 1, 2024
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Oct 1, 2024)
Oct 1, 2024
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 9900 (Introduced-in-House)


118th CONGRESS
2d Session
H. R. 9900


To modify the National Security Commission on Emergency Biotechnology.

IN THE HOUSE OF REPRESENTATIVES

October 1, 2024

Mr. Khanna introduced the following bill; which was referred to the Committee on Armed Services

A BILL

To modify the National Security Commission on Emergency Biotechnology.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “BioTech Innovation and National Security Continuation Act”.

SEC. 2. Modification of National Security Commission on Emerging Biotechnology.

Section 1091 of the National Defense Authorization Act for Fiscal Year 2022 (Public Law 117–81) is amended—

(1) in subsection (b)(3) by striking “the authority to make such appointment or appointments shall expire, and the number of members of the Commission shall be reduced by the number equal to the number of appointments so not made” and inserting “such appointments shall nevertheless be considered valid”;

(2) in subsection (g)(1), by inserting “and 6 months” after “3 years”; and

(3) in subsection (r), by striking “18 months after the date on which it submits the final report required by subsection (g)” and inserting “on December 31, 2026”.